Walleye Capital
EVH icon

Walleye Capital’s Evolent Health EVH Stock Holding History

Walleye Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,900
Closed -$84.3K – 4645
2025
Q1 		$84.3K Buy
+8,900
New +$89.9K ﹤0.01% 3679
2024
Q3 		– Sell
-3,900
Closed -$74.6K – 5432
2024
Q2 		$74.6K Buy
+3,900
New +$99.6K ﹤0.01% 4826
2023
Q2 		– Sell
-6,500
Closed -$211K – 4472
2023
Q1 		$211K Buy
+6,500
New +$206K ﹤0.01% 2429

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Capital's EVH Position: Q1 2026 in Review

Walleye Capital reduced its Evolent Health (EVH) stake by 2% in Q1 2026, selling an estimated $8.83K and leaving 135,948 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #3040.

Walleye Capital first reported a position in EVH in Q2 2019 and has held it in 11 quarters since. The position peaked at $7.29M in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Walleye Capital held 135,948 shares of Evolent Health worth $310K as of Q1 2026.
  • Walleye Capital sold 2,784 Evolent Health shares in Q1 2026, an estimated $8.83K.
  • Evolent Health made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3040 holding.
  • Walleye Capital first reported a position in Evolent Health in Q2 2019 and has held it in 11 quarters since.
  • Walleye Capital's Evolent Health position peaked at $7.29M in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.